Methotrexate 62332-0712
Product NDC
62332-0712- Manufacturer
- Alembic Pharmaceuticals Inc.
- Dosage Form
- Injection, Solution
- Route
- Intramuscular, Intrathecal, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 15, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA220225
Need to source Methotrexate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methotrexate Sodium | 25 mg/mL |
Drug Class
Folate Analog Metabolic Inhibitor [EPC]Folic Acid Metabolism Inhibitors [MoA]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (62332-712-01) / 40 mL in 1 VIAL, SINGLE-DOSE